Srkalovic, G., Schally, A. V., Wittliff, J. L., Day, Jr., T. G. and Jenison, E. L. Presence and Characteristics of Receptors for [D-Trp6]luteinizing Hormone Releasing Hormone and Epidermal Growth Factor in Human Ovarian Cancer. Intl. J. Oncol., 12:489-498, 1998.

Sanfilippo, J. S., Miseljic, S., Yang. A. R., Doering, D. L., Shaheen, R. M. and Wittliff, J. L. Quantitative Analyses of EGF Receptors, HER-2/neu Oncoprotein and Cathepsin D in Non-malignant and Malignant Uteri. Cancer, 77:710-716, 1996.

Miseljic, S., Yang, A-R, Cline, V. J. M. and Wittliff, J. L. Expression of Epidermal Growth Factor Receptors in Human Breast Cancer: Mass Versus Ligand Binding Capacity. The Breast J., 1:102-106, 1995.

Miseljic, S., Cavazos, A. S. and Wittliff, J. L. Influence of Menopausal Status on Expression of Epidermal Growth Factor Receptors, HER-2/neu Oncoprotein and Cathepsin D in Breast Cancer. J. Clin. Ligand Assay, 18:176-180, 1995.

Wittliff, J. L. Hormone and Growth Factor Receptors. In: W. L. Donegan and J. S. Spratt (ed.), Cancer of the Breast, Chapter 16, pp. 346-374, Philadelphia, PA: W. B. Saunders Co., 1995.

Halmos, G., Wittliff, J. L. and Schally, A. V. Characterization of Bombesin/Gastrin-releasing Peptide Receptors in Human Breast Cancer and Their Relationship to Steroid Receptor Expression. Cancer Res. 55:280-287, 1995.

Galandiuk, S., Miseljic, S., Yang, A.-R., Early, M., McCoy, M. D. and Wittliff, J. L. Expression of Hormone Receptors, Cathepsin-D, and HER-2/neu Oncoprotein in Normal Colon and Colonic Disease, Arch. Surg., 128:637-642, 1993.

Srkalovic, G., Wittliff, J. L. and Schally, A. V. Detection and Partial Characterization of Receptors for [D-Trp6]-Luteinizing Hormone-releasing Hormone and Epidermal Growth Factor in Human Endometrial Carcinoma. Cancer Res., 50:1841-1846, 1990.

Fekete, M., Wittliff, J. L. and Schally, A. V. Characteristics and Distribution of Receptors for [D-TRP6] Luteinizing Hormone Releasing Hormone, Somatosatin, Epidermal Growth Factor, and Sex Steroids in 500 Biopsy Samples of Human Breast Cancer. J. Clin. Lab. Analysis, 3:137-147, 1989.

Szende, B., Schally, A., Srkalovic, G., Comaru-Schally, A. M. and Wittliff, J. L. Adverse Effect of the Combination Tamoxifen and LH-RH Agonist Treatment on Estrogen Receptor-Negative Mammary Carcinoma. The Lancet #8656, 2:222-223, 1989.

Ben-David, M., Wittliff, J. L., Fekete, M., Kadar, T., Biran, S. and Schally, A. V. Lack of Relationship Between the Levels of Prolactin Receptors and Steroid Receptors in Woman With Breast Cancer. Biomed. & Pharmacother., 42:327-334, 1988.

Ben-David, M., Kadar, T., Wittliff, J. L., Biran, S. and Schally, A. Characterization of prolactin receptors and their distribution among American and Israeli Women with breast cancer: implications for prediction of hormonal dependency and treatment. Biomed. & Pharmacother., 42:101-109, 1988.